This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Trials Europe

Ignacio (Iggy) Handal
Chief Executive Officer at CLINICOM (& Winner of the 2022 Christine Pierre Clinical Trials Lifetime Achievement Award)


Ignacio Handal is currently CEO at Clinicom Healthcare. Ignacio has completed a myriad FDA phase I, II, & III studies in pharmaceuticals, and devices over two decades. Mr Handal has completed clinical studies that have help put 83 plus drugs and devices to market over the last twenty years, These products have touched the lives of over a two hundred million patients. In 2022 Ignacio was honored with the Christine Pierre Clinical trials global lifetime achievement award for clinical trials.

Mr. Handal has led the creation and development of two nationally recognized US clinical research centers, Harmonex Neuroscience Research and Trinity Research at Eye Center South. Harmonex Neuroscience is the clinical research institute that gave birth to Clinicom at its inception, Prior to Clinicom, Ignacio was Director of Clinical Project Management (10/2018-3/2020) and Director of Program Management (8/2018-2/2020) at Biorasi a global CRO. He was Director of Clinical Research at Eye Center South the Third largest surgical center in the USA from 2015-8/2018 where he founded their research division.

Early in his career Ignacio, Co-Founded the 5th leading private CNS research site in the US called Harmonex Neuroscience research in 2003 that continues to this day.

Ignacio and his team have used 100% of the profits of their research trials over the years to develop the world's first online mental health assessment software that can assess anyone remotely for 81 mental health conditions in one virtual assessment. Clinicom has helped accelerate enrollment and patient identification for precise inclusion and exclusion criteria in a multitude of phase II and III studies in the US. Ignacio and his team have invested over 10 million dollars from their clinical trials work to bring equity and access to mental health.

Agenda Sessions

  • Afternoon Coffee, Networking & Christine Pierre Clinical Trials Lifetime Achievement Award

  • Opening Remarks


At this event